- Home
- LFST vs CNTA Comparison
LFST vs CNTA Comparison
Compare LFST & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFST
- CNTA
- Stock Information
- Founded
- LFST 2015
- CNTA 2020
- Country
- LFST United States
- CNTA United Kingdom
- Employees
- LFST N/A
- CNTA N/A
- Industry
- LFST Medical/Nursing Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- LFST Health Care
- CNTA Health Care
- Exchange
- LFST Nasdaq
- CNTA Nasdaq
- Market Cap
- LFST 2.1B
- CNTA 2.3B
- IPO Year
- LFST 2021
- CNTA 2021
- Fundamental
- Price
- LFST $4.90
- CNTA $24.90
- Analyst Decision
- LFST Strong Buy
- CNTA Strong Buy
- Analyst Count
- LFST 5
- CNTA 9
- Target Price
- LFST $8.60
- CNTA $31.75
- AVG Volume (30 Days)
- LFST 1.3M
- CNTA 862.3K
- Earning Date
- LFST 11-06-2025
- CNTA 11-12-2025
- Dividend Yield
- LFST N/A
- CNTA N/A
- EPS Growth
- LFST N/A
- CNTA N/A
- EPS
- LFST N/A
- CNTA N/A
- Revenue
- LFST $1,316,483,000.00
- CNTA $15,000,000.00
- Revenue This Year
- LFST $15.35
- CNTA N/A
- Revenue Next Year
- LFST $14.14
- CNTA N/A
- P/E Ratio
- LFST N/A
- CNTA N/A
- Revenue Growth
- LFST 13.86
- CNTA 118.88
- 52 Week Low
- LFST $3.74
- CNTA $9.60
- 52 Week High
- LFST $8.61
- CNTA $25.31
- Technical
- Relative Strength Index (RSI)
- LFST 37.96
- CNTA 64.36
- Support Level
- LFST $5.05
- CNTA $23.45
- Resistance Level
- LFST $5.19
- CNTA $25.31
- Average True Range (ATR)
- LFST 0.15
- CNTA 0.91
- MACD
- LFST -0.03
- CNTA 0.05
- Stochastic Oscillator
- LFST 13.04
- CNTA 88.39
About LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.